BUSINESS ACQUISITIONS - Schedule of Contingent Consideration (Details) (USD $) In Thousands, unless otherwise specified	9 Months Ended						9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013		Sep. 30, 2014 Level 3 Potential Cash Consideration Fair Value	Jan. 15, 2014 Level 3 Potential Cash Consideration Fair Value	Dec. 31, 2013 Level 3 Potential Cash Consideration Fair Value	Sep. 30, 2014 Level 3 Selling, General and Administrative Expenses Potential Cash Consideration Fair Value
Business Acquisition, Contingent Consideration [Roll Forward]
Balance as of January 1, 2014				$ 21,244		$ 1,227
Contingent consideration from Confluent Surgical acquisition					20,895
Loss/(gain) from increase/(decrease) in fair value of contingent consideration liabilities	(878)	0	[1]				(878)
Fair value at September 30, 2014				$ 21,244		$ 1,227

[1] See Note 1 of these condensed consolidated financial statements for discussion of the impact of the change in accounting for the medical device excise tax.